ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Seer Inc

Seer Inc (SEER)

2.40
-0.01
(-0.41%)
At close: 11 January 8:00AM
2.40
0.00
( 0.00% )
After Hours: 8:46AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
2.40
Bid
2.27
Offer
2.45
Volume
157,326
2.305 Day's Range 2.40
1.51 52 Week Range 2.625
Market Cap
Previous Close
2.41
Open
2.356
Last Trade
1
@
2.4
Last Trade Time
08:00:08
Financial Volume
US$ 369,478
VWAP
2.3485
Average Volume (3m)
237,433
Shares Outstanding
58,966,560
Dividend Yield
-
PE Ratio
-1.64
Earnings Per Share (EPS)
-1.46
Revenue
16.66M
Net Profit
-86.28M

About Seer Inc

Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased... Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access across the proteome. Show more

Sector
Lab Analytical Instruments
Industry
Lab Analytical Instruments
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Seer Inc is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker SEER. The last closing price for Seer was US$2.41. Over the last year, Seer shares have traded in a share price range of US$ 1.51 to US$ 2.625.

Seer currently has 58,966,560 shares in issue. The market capitalisation of Seer is US$142.11 million. Seer has a price to earnings ratio (PE ratio) of -1.64.

SEER Latest News

Seer to Present at the J.P. Morgan 43rd Annual Healthcare Conference

REDWOOD CITY, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that...

Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

REDWOOD CITY, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced it...

Seer to Participate in Upcoming November Investor Conferences

REDWOOD CITY, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced company...

Seer Reports Third Quarter 2024 Financial Results

REDWOOD CITY, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today reported...

Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific

REDWOOD CITY, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced a...

Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer’s, Lung Cancer, and More at ASHG 2024

REDWOOD CITY, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, will showcase the...

Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer’s, Population Health, and Xenotransplantation at HUPO 2024

REDWOOD CITY, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a leading life science innovator shaping the future of proteomics, is set to present significant advancements...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.052.127659574472.352.4952.2952202002.43070881CS
4-0.045-1.840490797552.4452.522.1452187232.33119696CS
120.4724.35233160621.932.6251.822374332.28989754CS
260.8150.94339622641.592.6251.582987741.98283025CS
520.4925.65445026181.912.6251.514134861.87365584CS
156-16.05-86.991869918718.4521.4851.4553826254.95325719CS
260-45.6-954886.551.45541183716.50659384CS

SEER - Frequently Asked Questions (FAQ)

What is the current Seer share price?
The current share price of Seer is US$ 2.40
How many Seer shares are in issue?
Seer has 58,966,560 shares in issue
What is the market cap of Seer?
The market capitalisation of Seer is USD 142.11M
What is the 1 year trading range for Seer share price?
Seer has traded in the range of US$ 1.51 to US$ 2.625 during the past year
What is the PE ratio of Seer?
The price to earnings ratio of Seer is -1.64
What is the cash to sales ratio of Seer?
The cash to sales ratio of Seer is 8.5
What is the reporting currency for Seer?
Seer reports financial results in USD
What is the latest annual turnover for Seer?
The latest annual turnover of Seer is USD 16.66M
What is the latest annual profit for Seer?
The latest annual profit of Seer is USD -86.28M
What is the registered address of Seer?
The registered address for Seer is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Seer website address?
The website address for Seer is www.seer.bio
Which industry sector does Seer operate in?
Seer operates in the LAB ANALYTICAL INSTRUMENTS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TIRXTian Ruixiang Holdings Ltd
US$ 2.55
(52.69%)
1.68M
CJETChijet Motor Company Inc
US$ 2.50
(23.15%)
165.39k
RAYRaytech Holding Ltd
US$ 1.61
(19.26%)
317.91k
EHGOEshallgo Inc
US$ 3.75
(14.68%)
687
SNTSenstar Technologies Ltd
US$ 3.5853
(10.32%)
155
INTSIntesity Therapeutics Inc
US$ 1.90
(-11.53%)
248
VMARVision Marine Technologies Inc
US$ 1.92
(-10.70%)
881.1k
FAMIFarmmi Inc
US$ 0.3304
(-9.92%)
266.04k
XTKGX3 Holdings Company Ltd
US$ 1.25
(-8.76%)
4.08k
TLSATiziana Life Sciences Ltd
US$ 0.7679
(-8.58%)
63.45k
CDTConduit Pharmaceuticals Inc
US$ 0.1169
(-5.19%)
3.75M
NVDANVIDIA Corporation
US$ 136.00
(0.07%)
2.96M
PSIGPS International Group Ltd
US$ 0.5688
(7.52%)
2.14M
RGTIRigetti Computing Inc
US$ 8.56
(-4.14%)
1.84M
TIRXTian Ruixiang Holdings Ltd
US$ 2.55
(52.69%)
1.68M

Your Recent History

Delayed Upgrade Clock